February 6, 2023
VC News Daily
IgGenix Announces First Close of $40M Series B
SOUTH SAN FRANCISCO, CA, IgGenix, Inc., a pre-clinical biotechnology company, announced its first clo... See more »
Press Release: Aesthetics BioMedical : ABM Announces Cartessa Aesthetics To Be The Exclusive US Distributor For The Vivace
ABM Announces Cartessa Aesthetics To Be The Exclusive US Distributor For The Vivace(PRWeb February 22, 2018)Read the full story at http://www.prweb.com/releases/2018/02/prweb15230024.htm
Read full article »
February 6, 2023
PMLiVE
Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
Endometrial cancer is the sixth most common cancer in women worldwide and 15th most common cancer ove... See more »
February 6, 2023
Marketscreener
GSK : announces results from 17-year retrospective study on US clinical trial diversity
Study published today in Clinical Trials: Journal of the Society for Clinical Trials examined clinica... See more »
February 6, 2023FinSMEs
VitaDAO Closes $4.1M Funding Round
VitaDAO, a decentralized autonomous organization focused on raising funds for research on extending h... See more »
February 5, 2023Nasdaq
2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell
There are plenty of reasons why many investors enjoy holding shares in Johnson & Johnson (NYSE: JNJ),... See more »
February 6, 2023PharmaLive
Abbvie plans to lift $2 billion cap on deals - WSJ
Abbvie will lift a self-imposed $2 billion limit on acquisitions and mergers placed following a $63 b... See more »
February 6, 2023Endpoints News
Bristol Myers debuts first psoriasis drug ad on Grammys, leading chorus of pharma brands
Bristol Myers Squibb debuted its psoriasis med on one of the few remaining big mainstream TV stages o... See more »
February 6, 2023Indian Pharma Post
Janssen and Eli Lilly collaboration to address lack of pediatric therapies could rescue mirikizumab program, says GlobalData
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resou... See more »
February 6, 2023BioPharma-Reporter
Pfizer's 2023 pipeline: 'We potentially will have the largest number of new product and indication launches that we've ever had in such a short period of time'
Pfizer currently has an unprecedented number of anticipated launches, says its CEO: with the company ... See more »
February 6, 2023
VC News Daily
IgGenix Announces First Close of $40M Series B
SOUTH SAN FRANCISCO, CA, IgGenix, Inc., a pre-clinical biotechnology company, announced its first clo... See more »
February 6, 2023
PMLiVE
Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
Endometrial cancer is the sixth most common cancer in women worldwide and 15th most common cancer ove... See more »
February 6, 2023
Marketscreener
GSK : announces results from 17-year retrospective study on US clinical trial diversity
Study published today in Clinical Trials: Journal of the Society for Clinical Trials examined clinica... See more »
February 6, 2023FinSMEs
VitaDAO Closes $4.1M Funding Round
VitaDAO, a decentralized autonomous organization focused on raising funds for research on extending h... See more »
February 5, 2023Nasdaq
2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell
There are plenty of reasons why many investors enjoy holding shares in Johnson & Johnson (NYSE: JNJ),... See more »
February 6, 2023PharmaLive
Abbvie plans to lift $2 billion cap on deals - WSJ
Abbvie will lift a self-imposed $2 billion limit on acquisitions and mergers placed following a $63 b... See more »
February 6, 2023Endpoints News
Bristol Myers debuts first psoriasis drug ad on Grammys, leading chorus of pharma brands
Bristol Myers Squibb debuted its psoriasis med on one of the few remaining big mainstream TV stages o... See more »
February 6, 2023Indian Pharma Post
Janssen and Eli Lilly collaboration to address lack of pediatric therapies could rescue mirikizumab program, says GlobalData
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resou... See more »
February 6, 2023BioPharma-Reporter
Pfizer's 2023 pipeline: 'We potentially will have the largest number of new product and indication launches that we've ever had in such a short period of time'
Pfizer currently has an unprecedented number of anticipated launches, says its CEO: with the company ... See more »
CEO
Aesthetics BioMedical develops and distributes skin care products.
Read more